B. Carr Et Al. , "Erythrocyte Sedimentation Rate and Gamma-glutamyl Transpeptidase Combined are Potent Predictors of Survival and Tumor Characteristics in Hepatocellular Carcinoma Patients," Journal of Clinical Trials , vol.10, pp.1-10, 2020
Carr, B. Et Al. 2020. Erythrocyte Sedimentation Rate and Gamma-glutamyl Transpeptidase Combined are Potent Predictors of Survival and Tumor Characteristics in Hepatocellular Carcinoma Patients. Journal of Clinical Trials , vol.10 , 1-10.
Carr, B., AKKIZ, H., GÖZÜKARA BAĞ, H. G., GUERRA, V., DONGHIA, R., YALÇIN, K., ... KARAOĞULLARINDAN, Ü.(2020). Erythrocyte Sedimentation Rate and Gamma-glutamyl Transpeptidase Combined are Potent Predictors of Survival and Tumor Characteristics in Hepatocellular Carcinoma Patients. Journal of Clinical Trials , vol.10, 1-10.
Carr, Brian Et Al. "Erythrocyte Sedimentation Rate and Gamma-glutamyl Transpeptidase Combined are Potent Predictors of Survival and Tumor Characteristics in Hepatocellular Carcinoma Patients," Journal of Clinical Trials , vol.10, 1-10, 2020
Carr, Brian Et Al. "Erythrocyte Sedimentation Rate and Gamma-glutamyl Transpeptidase Combined are Potent Predictors of Survival and Tumor Characteristics in Hepatocellular Carcinoma Patients." Journal of Clinical Trials , vol.10, pp.1-10, 2020
Carr, B. Et Al. (2020) . "Erythrocyte Sedimentation Rate and Gamma-glutamyl Transpeptidase Combined are Potent Predictors of Survival and Tumor Characteristics in Hepatocellular Carcinoma Patients." Journal of Clinical Trials , vol.10, pp.1-10.
@article{article, author={Brian Carr Et Al. }, title={Erythrocyte Sedimentation Rate and Gamma-glutamyl Transpeptidase Combined are Potent Predictors of Survival and Tumor Characteristics in Hepatocellular Carcinoma Patients}, journal={Journal of Clinical Trials}, year=2020, pages={1-10} }